Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization

OK432-Activated Human Dendritic Cells Kill Tumor Cells via CD40/CD40 Ligand Interactions

(2014) K. S. Hill et al.   JOURNAL OF IMMUNOLOGY

Resection and liver transplantation for HCC

(2009) Jacques Belghiti   JOURNAL OF GASTROENTEROLOGY

The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology

(2009) Stephen Caldwell et al.   JOURNAL OF GASTROENTEROLOGY

A Combination Therapy of Gemcitabine With Immunotherapy for Patients With Inoperable Locally Advanced Pancreatic Cancer

(2009) Yoshiki Hirooka et al.   PANCREAS

Changes in arginase isoenzymes pattern in human hepatocellular carcinoma

(2008) Alicja Chrzanowska et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

(2008) Lotte Engell-Noerregaard et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cancer Immunotherapy by Dendritic Cells

(2008) Cornelis J.M. Melief   IMMUNITY

Recent Advances in Cancer Vaccines: An Overview

(2008) K. Itoh et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Expression of multidrug resistance-associated protein 3 and cytotoxic T cell responses in patients with hepatocellular carcinoma

(2008) Eishiro Mizukoshi et al.   JOURNAL OF HEPATOLOGY

Clinical Grade OK432-activated Dendritic Cells

(2008) Emma West et al.   JOURNAL OF IMMUNOTHERAPY